← Evidence map

ArticleBlood advances2026

Efficacy and safety of belumosudil as compared with best available therapy for the treatment of cGVHD in the United States.

Kevin Hall et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40875591